Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Apellis Pharmaceuticals, Inc. (APLS)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and APLS | ||
|---|---|---|
| S&P 500 | APLS | |
| Start Date | Dec-01-2017 | Dec-29-2017 |
| Start Price | $2,476.46 | $21.70 |
| End Date | May-01-2024 | May-17-2024 |
| End Price | $5,018.39 | $41.31 |
| Number Monthly Prices | 78 | 78 |
| Min Date | Dec-01-2018 | Dec-31-2018 |
| Min Price | $3,185.80 | $13.19 |
| Max Date | Apr-01-2024 | Jun-30-2023 |
| Max Price | $5,243.77 | $91.10 |
| Total Return | 48.94% | 90.37% |
| Annualized Return | 6.32% | 10.41% |
| Current Value of $1,000 Purchase | $1,489 | $1,904 |
| Number Returns | 3,003 | 3,003 |
| Average Return | 16.11% | 80.65% |
| Minimum Return | -25.54% | -71.73% |
| Maximum Return | 64.60% | 590.67% |
| Number Profitable Returns | 2,413 | 2,440 |
| Percent Profitable Returns | 80.35% | 81.25% |
| Number Unprofitable Returns | 590 | 563 |
| Percent Unprofitable Returns | 19.65% | 18.75% |
| Profitable to Unprofitable Returns Ratio | 4.09 | 4.33 |
APLS Performance Table and Chart
APLS Dollar-cost Average
APLS Trendline Chart
APLS Moving Average Chart
APLS Stock Return Map - See Patterns of Gains and Losses
APLS Stock Returns/Purchase Dates